Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot bronchoscopy could spot lung cancer earlier

NCT ID NCT07057648

Diagnosis Sponsor: Ulsan University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new robotic technology (ssRAB) to take tissue samples from lung nodules. Current methods work only about 70% of the time; the robot aims to be more accurate and safer. About 100 adults with lung nodules will undergo the procedure under anesthesia and be followed for 6 months. If successful, this approach could help diagnose lung cancer earlier and reduce the need for riskier procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with peripheral pulmonary nodules detected on chest CT imaging who require tissue sampling for histological diagnosis. Participants will be recruited from patients referred to the pulmonology department for evaluation of lung nodules. The study population includes patients with solid or part-solid nodules suspicious for malignancy or requiring tissue confirmation for clinical management decisions.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 19 years or older * Solid or part-solid peripheral pulmonary nodules confirmed on chest computed tomography (CT) * Patients requiring histological diagnosis as determined by the treating physician * Patients eligible for bronchoscopy procedure * Ability to provide written informed consent * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 or equivalent functional status allowing procedure under sedation or general anesthesia Exclusion Criteria: * Pure ground glass opacity nodules * Bleeding tendency defined as platelet count less than 50,000/μL or International Normalized Ratio (INR) greater than 1.5 * Severe cardiopulmonary dysfunction precluding deep sedation or general anesthesia * Pregnant or breastfeeding women * Life expectancy less than 6 months as assessed by the treating physician * Inability or unwillingness to provide informed consent * Absolute contraindication to bronchoscopy including: * Severe hypoxemia (oxygen saturation \<90% on room air) * Severe pulmonary hypertension * Recent myocardial infarction (within 6 weeks) * Unstable angina * Malignant arrhythmias * Participation in another interventional clinical trial that may interfere with study procedures or outcomes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchoscopy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm Multiple Pulmonary Nodules

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bronchoscopy Lung cancers Lung nodules Peripheral lung lesions Pulmonary nodules

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ulsan University Hospital

    RECRUITING

    Ulsan, 44033, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.